SLA 0.00% $3.34 silk laser australia limited

trials: no further need at the moment, page-30

  1. 1,621 Posts.
    lightbulb Created with Sketch. 18
    Those Bio-A cash figures were largely influenced by payment cycle of distributor (I rang to query them)
    I don't see Bio-A in Australia being significant for SLA, for some time if at all.
    Bio-A will only become significant (imo) if they can get it into some international health programmes eg for H.Porlori or for MRSA in hospitals.
 
watchlist Created with Sketch. Add SLA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.